Shim Clinic Logo
HIV PEP:
Stop HIV within 72 hours of sex
HIV Testing:
20 min result, 28 days after sex
STD Testing:
Full & comprehensive

Hepatitis B, Singapore - Shim Clinic

Hepatitis B Singapore: Hepatitis B is an infection of the liver caused by the Hepatitis B virus.

Hepatitis B infection is caused by the Hepatitis B virus and is usually screened for by detecting HBsAg in the blood. Immunity may be discerned by detecting HBsAb, and if absent, the Hepatitis B vaccine or Twinrix® vaccine may be given.

  • The hepatitis B virus is 100 times more infectious than HIV, the virus that causes AIDS, and infects about 10 times more people than HIV worldwide.
  • Hepatitis B virus infects the liver, and more than 350 million people in the world are lifelong hepatitis B virus carriers.
  • Long-term hepatitis B virus infection causes at least one million premature deaths every year from cirrhosis of the liver or liver cancer. It is second only to tobacco as the leading cause of cancer in humans.
  • Among the Hepatitis B carriers, 25% will develop serious liver diseases, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
  • The hepatitis B virus can be passed from an infected mother to her baby during childbirth, 1 in 20 Singaporeans are chronically infected with hepatitis B virus.


Blog articles about #hepatitisB


Latest News

HBIG Plus Antivirals May Prevent HBV Reinfection After Transplant HBIG Plus Antivirals May Prevent HBV Reinfection After Transplant
Tue, 23 May 2017 03:22:00 +0800 | Medscape Transplantation Headlines
A very short course of hepatitis B immunoglobulin (HBIG) after liver transplantation, along with long-term antiviral therapy, may prevent hepatitis B virus (HBV) reinfection, a retrospective study suggests.Reuters Health Information (Source: Medscape Transplantation Headlines)

Hepatitis B Surface Antigen Screening Among Pregnant Women and Care of Infants of Hepatitis B Surface Antigen-Positive Mothers — Guam, 2014
Fri, 19 May 2017 00:00:00 +0800 | CDC Morbidity and Mortality Weekly Report
(Source: CDC Morbidity and Mortality Weekly Report)

No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV
Wed, 26 Apr 2017 02:25:43 +0800 | Medscape Transplantation Headlines
The largest case review to date of hepatitis B virus (HBV) reactivation associated with direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection found no consistent pattern in terms of which patients are likely to develop this adverse event.Reuters Health Information (Source: Medscape Transplantation Headlines)

Anti-viral therapy during pregnancy reduces HBV transmission
Tue, 25 Apr 2017 00:12:21 +0800 | Health News - UPI.com
A new study has shown that an antiviral treatment given to women during pregnancy can help prevent transmission of hepatitis B from mother to child. (Source: Health News - UPI.com)

Prevent malaria - save lives: WHO push for prevention on World Malaria Day, 25th April
Mon, 24 Apr 2017 16:40:00 +0800 | WHO news
At an event on the eve of World Malaria Day in Nairobi, WHO called today for accelerated scale-up of efforts to prevent malaria and save lives. (Source: WHO news)

RECOMBIVAX HB (Hepatitis B Vaccine (Recombinant)) Injection, Suspension [A-S Medication Solutions]
Mon, 24 Apr 2017 12:00:00 +0800 | DailyMed Drug Label Updates
Updated Date: Apr 24, 2017 EST (Source: DailyMed Drug Label Updates)

‘ Large majority ’ of millions living with hepatitis have no access to testing or treatment – UN agency
Sat, 22 Apr 2017 01:45:21 +0800 | UN News Centre - Health, Poverty, Food Security
New data published by the United Nations health agency has revealed that a vast majority of the estimated 325 million people living with chronic hepatitis B virus or hepatitis C virus infection lack access to life-saving testing and treatment, placing them at a great risk of chronic liver disease, cancer, and even death. (Source: UN News Centre - Health, Poverty, Food Security)

Elevated Liver Cancer Risk for Older Hep B-Cleared Patients Elevated Liver Cancer Risk for Older Hep B-Cleared Patients
Fri, 21 Apr 2017 21:31:51 +0800 | Medscape Medical News Headlines
Even after a functional cure for hepatitis B is achieved, the risk for hepatocellular carcinoma persists in older patients, new research warns.Medscape Medical News (Source: Medscape Medical News Headlines)

New hepatitis data highlight need for urgent global response
Fri, 21 Apr 2017 17:32:41 +0800 | WHO news
New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and death. (Source: WHO news)

Nivolumab produces durable responses & long-term survival in severe liver cancer patients
Fri, 21 Apr 2017 11:00:00 +0800 | EurekAlert! - Cancer
(European Association for the Study of the Liver) Results from the CheckMate 040 study presented today found that nivolumab produces durable responses with long-term survival rates, regardless of whether or not patients were infected with Hepatitis B or C. Interim results from the study, presented at The International Liver Congress ™ 2017 in Amsterdam, The Netherlands, showed that the overall objective response rate (ORR) was 14.5 percent and ORR by investigator assessment was 19.3 percent in sorafenib-experienced patients in the dose expansion phase of CheckMate 040. (Source: EurekAlert! - Cancer)


Related Concepts

Vaccine

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis)
– Stop HIV infection before exposure
STD vaccine:
Hepatitis vaccine
HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV PEP (post-exposure prophylaxis)
– Stop HIV infection after exposure
STD testing *
Screening test
– to look for asymptomatic infections
– from previous exposures
Emergency contraception
with the
morning-after pill
(females only)
2 weeks HIV DNA Test
1 month HIV 4th Generation Test
SD Bioline HIV Ag/Ab Combo
– Fingerprick blood sampling.
20 minutes to results
3 months HIV 3rd Generation Test
OraQuick® HIV-1/2 Antibody
– Oral fluid or
– Fingerprick blood sampling.
20 minutes to results
STD testing *
– Full & comprehensive
diagnostic test
– to look for current infections
Watch for HIV Symptoms STD Symptoms
If infected HIV Treatment STD Treatment Abortion

* Males: Do not urinate for at least 4 hours before arriving.
* Females: testing is more accurate when you are not menstruating.


Private & Confidential Service